25.8625 USD
+0.35 (+1.38%)
Taking everything into account, PGNY scores 7 out of 10 in our fundamental rating. PGNY was compared to 102 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making PGNY a very profitable company, without any liquidiy or solvency issues. PGNY is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make PGNY suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year PGNY was profitable.
PGNY had a positive operating cash flow in the past year.
In the past 5 years PGNY has always been profitable.
PGNY had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
PGNY has a Return On Assets of 7.11%. This is amongst the best in the industry. PGNY outperforms 88.24% of its industry peers.
PGNY has a better Return On Equity (10.10%) than 71.57% of its industry peers.
PGNY has a better Return On Invested Capital (11.24%) than 83.33% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PGNY is in line with the industry average of 9.61%.
The 3 year average ROIC (8.25%) for PGNY is below the current ROIC(11.24%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| ROIC | 11.24% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
1.3 Margins
PGNY has a Profit Margin of 4.46%. This is in the better half of the industry: PGNY outperforms 77.45% of its industry peers.
In the last couple of years the Profit Margin of PGNY has declined.
The Operating Margin of PGNY (6.77%) is better than 69.61% of its industry peers.
In the last couple of years the Operating Margin of PGNY has grown nicely.
PGNY has a Gross Margin of 22.94%. This is comparable to the rest of the industry: PGNY outperforms 47.06% of its industry peers.
PGNY's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.77% | ||
| PM (TTM) | 4.46% | ||
| GM | 22.94% |
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PGNY is still creating some value.
The number of shares outstanding for PGNY has been reduced compared to 1 year ago.
PGNY has more shares outstanding than it did 5 years ago.
PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 8.52 indicates that PGNY is not in any danger for bankruptcy at the moment.
PGNY has a better Altman-Z score (8.52) than 93.14% of its industry peers.
There is no outstanding debt for PGNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.52 |
ROIC/WACC1.27
WACC8.88%
2.3 Liquidity
A Current Ratio of 2.96 indicates that PGNY has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.96, PGNY belongs to the top of the industry, outperforming 84.31% of the companies in the same industry.
PGNY has a Quick Ratio of 2.96. This indicates that PGNY is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of PGNY (2.96) is better than 84.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.96 |
3. Growth
3.1 Past
PGNY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.62%, which is quite good.
PGNY shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.77% yearly.
PGNY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.41%.
The Revenue has been growing by 38.42% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)8.62%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%36.36%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.32%
3.2 Future
Based on estimates for the next years, PGNY will show a very strong growth in Earnings Per Share. The EPS will grow by 32.94% on average per year.
PGNY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.83% yearly.
EPS Next Y38.33%
EPS Next 2Y37.34%
EPS Next 3Y31.32%
EPS Next 5Y32.94%
Revenue Next Year11.28%
Revenue Next 2Y10.4%
Revenue Next 3Y10.53%
Revenue Next 5Y8.83%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 41.05, PGNY can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as PGNY.
PGNY's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.59.
PGNY is valuated rather expensively with a Price/Forward Earnings ratio of 24.06.
The rest of the industry has a similar Price/Forward Earnings ratio as PGNY.
When comparing the Price/Forward Earnings ratio of PGNY to the average of the S&P500 Index (24.03), we can say PGNY is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.05 | ||
| Fwd PE | 24.06 |
4.2 Price Multiples
PGNY's Enterprise Value to EBITDA ratio is in line with the industry average.
PGNY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PGNY is cheaper than 82.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.52 | ||
| EV/EBITDA | 18.19 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PGNY has a very decent profitability rating, which may justify a higher PE ratio.
PGNY's earnings are expected to grow with 31.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.07
PEG (5Y)N/A
EPS Next 2Y37.34%
EPS Next 3Y31.32%
5. Dividend
5.1 Amount
PGNY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:PGNY (12/26/2025, 2:01:09 PM)
25.8625
+0.35 (+1.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.97%
Inst Owner Change7.39%
Ins Owners1.49%
Ins Owner Change0.8%
Market Cap2.23B
Revenue(TTM)1.27B
Net Income(TTM)56.57M
Analysts81.25
Price TargetN/A
Short Float %6.68%
Short Ratio3.12
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.43%
Min EPS beat(2)14.22%
Max EPS beat(2)14.63%
EPS beat(4)3
Avg EPS beat(4)8.02%
Min EPS beat(4)-11.77%
Max EPS beat(4)15%
EPS beat(8)5
Avg EPS beat(8)7.07%
EPS beat(12)9
Avg EPS beat(12)35.08%
EPS beat(16)13
Avg EPS beat(16)94.29%
Revenue beat(2)2
Avg Revenue beat(2)2.31%
Min Revenue beat(2)1.96%
Max Revenue beat(2)2.66%
Revenue beat(4)4
Avg Revenue beat(4)3.39%
Min Revenue beat(4)1.96%
Max Revenue beat(4)5.74%
Revenue beat(8)4
Avg Revenue beat(8)-0.43%
Revenue beat(12)7
Avg Revenue beat(12)0.39%
Revenue beat(16)9
Avg Revenue beat(16)-0.09%
PT rev (1m)1.38%
PT rev (3m)1.38%
EPS NQ rev (1m)0.87%
EPS NQ rev (3m)5.45%
EPS NY rev (1m)24.93%
EPS NY rev (3m)28.22%
Revenue NQ rev (1m)-0.37%
Revenue NQ rev (3m)1.13%
Revenue NY rev (1m)1.4%
Revenue NY rev (3m)1.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.05 | ||
| Fwd PE | 24.06 | ||
| P/S | 1.76 | ||
| P/FCF | 11.52 | ||
| P/OCF | 10.71 | ||
| P/B | 3.98 | ||
| P/tB | 4.18 | ||
| EV/EBITDA | 18.19 |
EPS(TTM)0.63
EY2.44%
EPS(NY)1.08
Fwd EY4.16%
FCF(TTM)2.24
FCFY8.68%
OCF(TTM)2.41
OCFY9.34%
SpS14.72
BVpS6.5
TBVpS6.19
PEG (NY)1.07
PEG (5Y)N/A
Graham Number9.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| ROCE | 14.68% | ||
| ROIC | 11.24% | ||
| ROICexc | 27.43% | ||
| ROICexgc | 30.82% | ||
| OM | 6.77% | ||
| PM (TTM) | 4.46% | ||
| GM | 22.94% | ||
| FCFM | 15.25% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
ROICexc(3y)19.18%
ROICexc(5y)17.15%
ROICexgc(3y)20.6%
ROICexgc(5y)18.86%
ROCE(3y)10.79%
ROCE(5y)10.01%
ROICexgc growth 3Y11.16%
ROICexgc growth 5Y-10.91%
ROICexc growth 3Y11.54%
ROICexc growth 5Y-2.19%
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
F-Score7
Asset Turnover1.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 330.21% | ||
| Cap/Sales | 1.16% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 230.54% | ||
| Profit Quality | 342.01% | ||
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.96 | ||
| Altman-Z | 8.52 |
F-Score7
WACC8.88%
ROIC/WACC1.27
Cap/Depr(3y)177.5%
Cap/Depr(5y)150.16%
Cap/Sales(3y)0.4%
Cap/Sales(5y)0.39%
Profit Quality(3y)290.66%
Profit Quality(5y)196.79%
High Growth Momentum
Growth
EPS 1Y (TTM)8.62%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%36.36%
EPS Next Y38.33%
EPS Next 2Y37.34%
EPS Next 3Y31.32%
EPS Next 5Y32.94%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.32%
Revenue Next Year11.28%
Revenue Next 2Y10.4%
Revenue Next 3Y10.53%
Revenue Next 5Y8.83%
EBIT growth 1Y31.12%
EBIT growth 3Y27.82%
EBIT growth 5Y41.01%
EBIT Next Year39.63%
EBIT Next 3Y20.17%
EBIT Next 5Y15.66%
FCF growth 1Y-2.78%
FCF growth 3Y93.67%
FCF growth 5YN/A
OCF growth 1Y2.69%
OCF growth 3Y90.18%
OCF growth 5YN/A
PROGYNY INC / PGNY FAQ
What is the fundamental rating for PGNY stock?
ChartMill assigns a fundamental rating of 7 / 10 to PGNY.
What is the valuation status for PGNY stock?
ChartMill assigns a valuation rating of 5 / 10 to PROGYNY INC (PGNY). This can be considered as Fairly Valued.
How profitable is PROGYNY INC (PGNY) stock?
PROGYNY INC (PGNY) has a profitability rating of 7 / 10.
What are the PE and PB ratios of PROGYNY INC (PGNY) stock?
The Price/Earnings (PE) ratio for PROGYNY INC (PGNY) is 41.05 and the Price/Book (PB) ratio is 3.98.
Can you provide the expected EPS growth for PGNY stock?
The Earnings per Share (EPS) of PROGYNY INC (PGNY) is expected to grow by 38.33% in the next year.